The global Drug-eluting Microsphere market  size is set to grow from  US$ 855 million in 2025 to US$ 2091 million in 2031; it is expected to grow at a CAGR of 16.1% from 2025 to 2031.

Global Drug-eluting Microsphere Market Growth and Outlook 2025-31

The global Drug-eluting Microsphere market size is predicted to grow from US$ 855 million in 2025 to US$ 2091 million in 2031; it is expected to grow at a CAGR of 16.1% from 2025 to 2031. Drug-eluting Microsphere, delivered by transarterial chemoembolization (TACE) serve as a therapeutic embolic to stop blood flow to tumors and a drug delivery vehicle. United States market for Drug-eluting Microsphere is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Drug-eluting Microsphere is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Drug-eluting Microsphere is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Drug-eluting Microsphere players cover Boston Scientific, Merit Medical, Terumo, Suzhou Hengrui Medical, Varian, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Drug-eluting Microsphere Industry Forecast looks at past sales and reviews total world Drug-eluting Microsphere sales in 2024, providing a comprehensive analysis by region and market sector of projected Drug-eluting Microsphere sales for 2025 through 2031. With Drug-eluting Microsphere sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug-eluting Microsphere industry. This Insight Report provides a comprehensive analysis of the global Drug-eluting Microsphere landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug-eluting Microsphere portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Drug-eluting Microsphere market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug-eluting Microsphere and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug-eluting Microsphere. This report presents a comprehensive overview, market shares, and growth opportunities of Drug-eluting Microsphere market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; 70?150?m &nbsp;&nbsp;&nbsp; 100?300?m &nbsp;&nbsp;&nbsp; 300?500?m &nbsp;&nbsp;&nbsp; Other Segmentation by Application: &nbsp;&nbsp;&nbsp; Transcatheter Hepatic Arterial Chemoembolization &nbsp;&nbsp;&nbsp; Other This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Boston Scientific &nbsp;&nbsp;&nbsp; Merit Medical &nbsp;&nbsp;&nbsp; Terumo &nbsp;&nbsp;&nbsp; Suzhou Hengrui Medical &nbsp;&nbsp;&nbsp; Varian &nbsp;&nbsp;&nbsp; Cardiolink Science Key Questions Addressed in this Report What is the 10-year outlook for the global Drug-eluting Microsphere market? What factors are driving Drug-eluting Microsphere market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Drug-eluting Microsphere market opportunities vary by end market size? How does Drug-eluting Microsphere break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Drug-eluting Microsphere Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Drug-eluting Microsphere by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Drug-eluting Microsphere by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Drug-eluting Microsphere Segment by Type &nbsp;2.2.1 70?150?m &nbsp;2.2.2 100?300?m &nbsp;2.2.3 300?500?m &nbsp;2.2.4 Other &nbsp;2.3 Drug-eluting Microsphere Sales by Type &nbsp;2.3.1 Global Drug-eluting Microsphere Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Drug-eluting Microsphere Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Drug-eluting Microsphere Sale Price by Type (2020-2025) &nbsp;2.4 Drug-eluting Microsphere Segment by Application &nbsp;2.4.1 Transcatheter Hepatic Arterial Chemoembolization &nbsp;2.4.2 Other &nbsp;2.5 Drug-eluting Microsphere Sales by Application &nbsp;2.5.1 Global Drug-eluting Microsphere Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Drug-eluting Microsphere Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Drug-eluting Microsphere Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Drug-eluting Microsphere Breakdown Data by Company &nbsp;3.1.1 Global Drug-eluting Microsphere Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Drug-eluting Microsphere Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Drug-eluting Microsphere Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Drug-eluting Microsphere Revenue by Company (2020-2025) &nbsp;3.2.2 Global Drug-eluting Microsphere Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Drug-eluting Microsphere Sale Price by Company &nbsp;3.4 Key Manufacturers Drug-eluting Microsphere Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Drug-eluting Microsphere Product Location Distribution &nbsp;3.4.2 Players Drug-eluting Microsphere Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Drug-eluting Microsphere by Geographic Region &nbsp;4.1 World Historic Drug-eluting Microsphere Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Drug-eluting Microsphere Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Drug-eluting Microsphere Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Drug-eluting Microsphere Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Drug-eluting Microsphere Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Drug-eluting Microsphere Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Drug-eluting Microsphere Sales Growth &nbsp;4.4 APAC Drug-eluting Microsphere Sales Growth &nbsp;4.5 Europe Drug-eluting Microsphere Sales Growth &nbsp;4.6 Middle East & Africa Drug-eluting Microsphere Sales Growth 5 Americas &nbsp;5.1 Americas Drug-eluting Microsphere Sales by Country &nbsp;5.1.1 Americas Drug-eluting Microsphere Sales by Country (2020-2025) &nbsp;5.1.2 Americas Drug-eluting Microsphere Revenue by Country (2020-2025) &nbsp;5.2 Americas Drug-eluting Microsphere Sales by Type (2020-2025) &nbsp;5.3 Americas Drug-eluting Microsphere Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Drug-eluting Microsphere Sales by Region &nbsp;6.1.1 APAC Drug-eluting Microsphere Sales by Region (2020-2025) &nbsp;6.1.2 APAC Drug-eluting Microsphere Revenue by Region (2020-2025) &nbsp;6.2 APAC Drug-eluting Microsphere Sales by Type (2020-2025) &nbsp;6.3 APAC Drug-eluting Microsphere Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Drug-eluting Microsphere by Country &nbsp;7.1.1 Europe Drug-eluting Microsphere Sales by Country (2020-2025) &nbsp;7.1.2 Europe Drug-eluting Microsphere Revenue by Country (2020-2025) &nbsp;7.2 Europe Drug-eluting Microsphere Sales by Type (2020-2025) &nbsp;7.3 Europe Drug-eluting Microsphere Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Drug-eluting Microsphere by Country &nbsp;8.1.1 Middle East & Africa Drug-eluting Microsphere Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Drug-eluting Microsphere Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Drug-eluting Microsphere Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Drug-eluting Microsphere Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Drug-eluting Microsphere &nbsp;10.3 Manufacturing Process Analysis of Drug-eluting Microsphere &nbsp;10.4 Industry Chain Structure of Drug-eluting Microsphere 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Drug-eluting Microsphere Distributors &nbsp;11.3 Drug-eluting Microsphere Customer 12 World Forecast Review for Drug-eluting Microsphere by Geographic Region &nbsp;12.1 Global Drug-eluting Microsphere Market Size Forecast by Region &nbsp;12.1.1 Global Drug-eluting Microsphere Forecast by Region (2026-2031) &nbsp;12.1.2 Global Drug-eluting Microsphere Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Drug-eluting Microsphere Forecast by Type (2026-2031) &nbsp;12.7 Global Drug-eluting Microsphere Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Boston Scientific &nbsp;13.1.1 Boston Scientific Company Information &nbsp;13.1.2 Boston Scientific Drug-eluting Microsphere Product Portfolios and Specifications &nbsp;13.1.3 Boston Scientific Drug-eluting Microsphere Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Boston Scientific Main Business Overview &nbsp;13.1.5 Boston Scientific Latest Developments &nbsp;13.2 Merit Medical &nbsp;13.2.1 Merit Medical Company Information &nbsp;13.2.2 Merit Medical Drug-eluting Microsphere Product Portfolios and Specifications &nbsp;13.2.3 Merit Medical Drug-eluting Microsphere Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Merit Medical Main Business Overview &nbsp;13.2.5 Merit Medical Latest Developments &nbsp;13.3 Terumo &nbsp;13.3.1 Terumo Company Information &nbsp;13.3.2 Terumo Drug-eluting Microsphere Product Portfolios and Specifications &nbsp;13.3.3 Terumo Drug-eluting Microsphere Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Terumo Main Business Overview &nbsp;13.3.5 Terumo Latest Developments &nbsp;13.4 Suzhou Hengrui Medical &nbsp;13.4.1 Suzhou Hengrui Medical Company Information &nbsp;13.4.2 Suzhou Hengrui Medical Drug-eluting Microsphere Product Portfolios and Specifications &nbsp;13.4.3 Suzhou Hengrui Medical Drug-eluting Microsphere Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Suzhou Hengrui Medical Main Business Overview &nbsp;13.4.5 Suzhou Hengrui Medical Latest Developments &nbsp;13.5 Varian &nbsp;13.5.1 Varian Company Information &nbsp;13.5.2 Varian Drug-eluting Microsphere Product Portfolios and Specifications &nbsp;13.5.3 Varian Drug-eluting Microsphere Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Varian Main Business Overview &nbsp;13.5.5 Varian Latest Developments &nbsp;13.6 Cardiolink Science &nbsp;13.6.1 Cardiolink Science Company Information &nbsp;13.6.2 Cardiolink Science Drug-eluting Microsphere Product Portfolios and Specifications &nbsp;13.6.3 Cardiolink Science Drug-eluting Microsphere Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Cardiolink Science Main Business Overview &nbsp;13.6.5 Cardiolink Science Latest Developments 14 Research Findings and Conclusion

Report	Global Drug-eluting Microsphere Market Growth 2025-2031
Selected License	Multi ID: LPI16961

Buyer Information

Order Summary